AllTrna was founded by Lovisa Afzelius in 2018.

Who are AllTrna's investors?

AllTrna's investors include Flagship Pioneering.

AllTrna

Founded 2018 · 43 employees on LinkedIn · 1 known investors

Find your way into AllTrna

190 people in our graph share verified history with the AllTrna team — schools, employers, funds. One of them is your warm intro.

Mojca Skoberneunlockedknows Lovisa Afzelius · together at Repertoire Immune Medicines (overlapped)

×6knows the team · via MIT Sloan School of Management

×5knows the team · via Flagship Pioneering

Alltrna develops engineered, chemically modified tRNA oligonucleotides as programmable medicines, using proprietary machine learning tools to design tRNA molecules with desired pharmacologic properties. Its initial therapeutic focus is treating nonsense mutations by reading through premature termination codons to restore full-length protein production, addressing a category it calls Stop Codon Disease.

AI & Machine Learning Biotech Deep Tech Healthtech

Founders & leadership

AllTrna was founded in 2018 by Lovisa Afzelius.

Lovisa Afzelius inExecutive Chair & Founding CEOLovisa Afzelius is a general partner at Flagship Pioneering with two decades of leadership experience across biotech and pharmaceutical companies, including CEO and board positions. She holds a background in computational science and has worked on data-driven drug discovery programs spanning early development through clinical stages across multiple therapeutic areas.

Michelle WernerinCEO

Joanne ProtanoinPresident & Chief Financial OfficerExecutive Officer at Rubius Therapeutics

Dave HavainChief Scientific Officer

Nerissa KreherinChief Medical OfficerExecutive Officer at Entrada Therapeutics, Inc.

Caroline KöhrerinSVP, Discovery Platform

Investors · 1

Flagship Pioneering✓ verifiedCambridge · $500K – $10M

Founder mafia

3 people who came through AllTrna went on to found or lead other companies.

Noubar AfeyanFounding ChairmanFounded ProFound Therapeutics +13 Lovisa AfzeliusExecutive Chair & Founding CEOFounded Metaphorebio +1 Austin DraycottConsultantFounded Cloverleafbio

Frequently asked questions

What does AllTrna do?: Alltrna develops engineered, chemically modified tRNA oligonucleotides as programmable medicines, using proprietary machine learning tools to design tRNA molecules with desired pharmacologic properties. Its initial therapeutic focus is treating nonsense mutations by reading through premature termination codons to restore full-length protein production, addressing a category it calls Stop Codon Disease.
Who founded AllTrna?: AllTrna was founded by Lovisa Afzelius in 2018.
Who are AllTrna's investors?: AllTrna's investors include Flagship Pioneering.